Connor, Clark & Lunn Investment Management Ltd. Embecta Corp. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Embecta Corp. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 161,044 shares of EMBC stock, worth $1.98 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
161,044
Previous 203,050
20.69%
Holding current value
$1.98 Million
Previous $2.86 Million
16.8%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding EMBC
# of Institutions
407Shares Held
52.4MCall Options Held
120KPut Options Held
66.8K-
Black Rock Inc. New York, NY9.19MShares$113 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.03MShares$86.3 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.27MShares$40.2 Million1.68% of portfolio
-
American Century Companies Inc Kansas City, MO3.26MShares$40.1 Million0.04% of portfolio
-
River Road Asset Management, LLC3.25MShares$39.9 Million0.95% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $710M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...